Cancer Institute A national cancer institute
designated cancer center

Department: Stanford Cancer Institute

Hematopoietic Cell Transplant

  • Assistant Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Hematology
    • Blood and Marrow Transplantation
    Research Interest

    Research interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.

  • Vice Provost and Dean of Research, Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Clinical Focus
    • Infectious Diseases, Pediatric
    • Pediatric Infectious Disease
    Research Interest

    Our laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections.

  • Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Blood and Marrow Transplantation
    • Blood and Marrow Transplantation / Infectious Diseases
  • Professor of Medicine (Hematology), Emeritus
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Hematology
    • Hematology
    • Myelodysplastic Syndromes
    Research Interest

    Regulation of hematopoiesis in myeloid malignancies with special emphasis on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Laboratory studies utilize DNA microarrays to determine differential gene expression in MDS and AML. Transcriptomic abnormalities are also being evaluated using RNA-Seq and proteomic technologies. Translational clinical studies focus on using specific biologic targeting agents to treat these disorders.

  • Associate Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Hematology
    • Blood and Marrow Transplantation
    Research Interest

    Clinical research in allogeneic and autologous hematopoietic cell transplantation (HCT), more specifically, allogeneic transplantation and graft versus host disease. Exploring methods of improving prevention and treatment of GVHD as well as the long term follow-up and/or quality of life of affected patients.

  • Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Hematology
    • Blood and Marrow Transplantation
    Research Interest

    haploidentical transplantation, follicular lymphoma, adoptive immunotherapy,supportive care

  • Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Hematology
    • Blood and Marrow Transplantation
    Research Interest

    Dr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.

  • Assistant Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Hematology
    • Blood Stem Cell Transplant
    Research Interest

    Investigates the targets of immune responses after human allogeneic stem cell transplantation. BMT patients develop antibodies against minor histocompatibility antigens (mHA) that are associated with chronic graft-v-host disease (cGVHD) and disease remission. Current projects: investigate Ab anti-tumor mechanism, high-throughput serologic identification of novel mHA in the development of GVHD and prevention of disease relapse, and clinical trials of B cell therapeutics for cGVHD.

  • Professor of Medicine (Blood and Marrow Transplantation)
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Hematology
    • Blood and Marrow Transplantation
    Research Interest

    Our labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells.

  • Professor of Structural Biology and of Microbiology and Immunology
    Member, Stanford Cancer Institute
    Research Interest

    The Parham laboratory investigates the biology, genetics, and evolution of MHC class I molecules and NK cell receptors.

  • Professor of Medicine (Immunology and Rheumatology)
    Member, Stanford Cancer Institute
    Clinical Focus
    • Immunology and Rheumatology
    • Rheumatology
    Research Interest

    Mechanisms of immune tolerance; regulatory processes in autoimmunity and transplantation and extrathymic T cell maturation.

  • Anne T. and Robert M. Bass Professor in Pediatric Cancer and Blood Diseases
    Member, Stanford Cancer Institute
    Clinical Focus
    • Hematology, Pediatric
    • Oncology (Cancer), Pediatric
    • Pediatric Hematology-Oncology

Stanford Medicine Resources:

Footer Links: